1 completed, 1 terminated, 1 withdrawn. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
Follow ARDS, Human: new trials by email Literature Review of ARDS, Human trials Research Report on ARDS, Human
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury Heparin, 0.9% Sodium-chloride - Covid-19, ARDS, Human | Phase 4 | Terminated | Frederick Health | 13 | 2020-06-01 | 2024-04-03 |
| The Use of Tadalafil in Confirmed COVID-19 Pneumonia. Tadalafil Pill - COVID, Sars-CoV2 | Phase 4 | Withdrawn | Santa Barbara Cottage Hospital | 2020-04-20 | 2021-07-02 | |
| The Study of Pharmacokinetics and Pharmacodynamics of Cisatracurium cisatracurium - Critical Illness, Respiratory Distress Syndrome, Adult | Phase 4 | Completed | Mahidol University | 10 | 2017-12-15 | 2019-03-06 |
Respiratory Distress Syndrome (3) · Acute Lung Injury (1) · COVID-19 (1) · Critical Illness (1) · Paralysis (1) · Respiratory Insufficiency (1)
Lung Diseases (3) · Respiration Disorders (3) · Respiratory Tract Diseases (3) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Disease Attributes (1) · Infections (1) · Lung Injury (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Nidovirales Infections (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pneumonia (1) · Pneumonia, Viral (1)
Heparin (1) · Sodium Chloride (1) · Tadalafil (1) · cisatracurium (1)
Frederick Health (1) · Mahidol University (1) · Santa Barbara Cottage Hospital (1)
Thailand (1) · United States (1)